It gives us great pleasure to present the annual 13th edition of the International Symposium on Neuropsychiatry & VIH.
We have been organizing this meeting during the last 12 years with an enormous success due the high level of our speakers and attendees, the high interest and participation in the workshops and the high value of some time for networking and interpersonal meeting. The past editions of the symposium have taken place in Barcelona, one of the most spectacular cities in Spain.
Since its first edition, this Symposium has been addressed to those health professionals who have healthcare or scientific interest in promoting neuropsychological and neuropsychiatric health of people with HIV. Its program has an eminently practical character, as it includes topics related to the medical field such as: detection and management of the most frequent problems (depression or neurocognitive impairment), knowledge of the neuropsychological effects of antiretrovirals, the adverse effects of psychopharmacological treatments, and and the consideration of the more outstanding interactions between both groups of medicines.
This Symposium has consolidated as a forum for discussing the latest researches on central nervous system aspects affected by HIV. In previous editions, attendees were able to learn about some basic notions that are very useful for their daily clinical practice in terms of improving the management of psychiatric and neuropsychological problems in their patients.
Due to the uncertainty caused by the Covid-19 in Spain and around the world, we have been forced to postpone the date of this year’s edition. We have also had to adapt the format and the content. We decided to modify the format from a standard face-to-face meeting to a virtual one. Instead of a one and a half day meeting, we have distributed the program into 5 shorter webinars (3 main sessions and 2 round tables, all 90 minutes long). The webinars will be carried out during 2 weeks at the end of October and the first one in November 2020. We have also updated the content of the Symposium, including references to the SARS-CoV-2 pandemics. We have considered including the perspective of the impact of SARS-CoV-2 on people with HIV/AIDS, choosing topics that might be of special interest to HIV professionals.
At the 13th International Symposium on Neuropsychiatry & VIH will discuss new knowledge and research in the field of HIV and/or SARS-CoV-2 effects on CNS. We will also discuss about the psychological and psychiatric impact of the lockdown and the socio-economic consequences of the pandemic in people with HIV.
In any case, all these changes will not change the aim of this annual Symposium. We are convinced that this event will keep high the interest of the attendees, as well as the quality of the previous editions.
Jordi Blanch, MD.
Psychiatry Unit. Hospital U. Clinic. Barcelona, Spain
Esteban Martinez, MD.
Infectious Diseases Unit. Hospital U. Clinic. Barcelona, Spain
We’ll be very thankful to you if you share this information with all of those who can be interested in it.
We look forward to your active participation.
See you in October!
Jordi Blanch and Esteban Martínez